For years, the antimicrobial claim on sanitary pads was backed only by lab tests at the factory gate. The release of T/CIAA 008—2026 in August 2026 changes that by introducing a 'long-lasting antimicrobial' requirement that simulates post-use conditions. This is not just a test method upgrade; it forces the entire supply chain to rethink how efficacy is validated.
Key Changes in the Updated Standard
The most visible change is expanding the product scope from 'bacteriostatic sanitary pads' to 'antimicrobial sanitary pads, pantyliners and period pants,' officially bringing period underwear into the regulatory framework. Previously, period pants were often managed as apparel or general hygiene products, lacking a unified basis for antimicrobial claims. Now, the standard sets a clear performance boundary for this emerging category.
More critical is the definition of 'long-lasting antimicrobial (bacteriostatic).' According to T/CIAA 008—2026, the product's skin-contact layer must be treated with bovine serum albumin and placed at (36±1)°C for no less than 8 hours to simulate actual use, after which the product must still exhibit antimicrobial activity. This directly targets a known industry weakness—many products show high initial kill rates but degrade after a few hours of use. The new standard aims to push formulation and structural improvements through a more realistic test scenario.
Additionally, the standard aligns with GB 15979-2024, updating requirements for antibacterial performance, bacteriostatic performance, stability, and toxicology, along with corresponding test methods. Companies wishing to claim 'antibacterial' or 'bacteriostatic' must now meet both the national baseline and the group standard's added performance criteria, lengthening the compliance chain.
Ripple Effects on Industrial Clusters
The revision is not an isolated event; it directly impacts suppliers of nonwovens, films, and functional additives. The top sheet, absorbent core, and back sheet are key to functionality. The long-lasting requirement will push companies to re-evaluate antimicrobial agents—whether zinc-based, silver-based, quaternary ammonium compounds, or natural extracts—since their durability and safety profiles will determine success in the new test.
For hygiene product clusters in Fujian Jinjiang, Zhejiang Yiwu, and Guangdong, the new standard is both a challenge and an opportunity. Small factories lacking R&D may exit the antimicrobial segment if they cannot meet the long-lasting test, while tech-savvy leaders can consolidate market share. For buyers, future inspections must go beyond routine bacterial reduction rates to include durability data, requiring stronger technical due diligence.
On the export front, although group standards are voluntary, they carry de facto influence in the domestic market. Some overseas buyers reference advanced Chinese standards, and the 'long-lasting' concept could become a plus if recognized internationally. However, whether the use of bovine serum albumin and the simulation conditions align with EU, US, or Japanese testing protocols remains to be verified by exporters.
Practical Recommendations
For Buyers - Add a review of 'long-lasting antimicrobial' test reports in supplier audits, requiring data from simulated-use conditions. - Verify that product packaging explicitly cites T/CIAA 008—2026 to avoid sourcing old-stock items claiming antimicrobial efficacy under the previous standard. - For period pants, confirm suppliers have updated definitions and performance claims to the new standard to prevent marketing mismatches.
For Manufacturers - Align existing product lines with GB 15979-2024 and T/CIAA 008—2026 by re-evaluating antimicrobial agent selection and application processes, conducting long-lasting efficacy validation early. - Partner with accredited third-party labs (e.g., SGS, Guangdong Institute of Microbiology) to ensure test methods meet new requirements. - Monitor the cost and supply stability of bovine serum albumin, assess its impact on pricing, and optimize formulations to balance performance and cost.
The new standard will not be implemented overnight, but the direction is clear: antimicrobial hygiene products are shifting from 'concept marketing' to 'evidence-based compliance.' Whether you are a brand, a contract manufacturer, or a raw material supplier, early adjustment of validation systems will secure a competitive edge in the next round of market competition.